ClinicalTrials.gg
Sign In

Leukemia, Lymphoid clinical trials

The registry lists 92 studies for Leukemia, Lymphoid across more than 10 countries. 14 are recruiting or about to start. 25 of them are mainly about Leukemia, Lymphoid (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03. Counting its 11 narrower conditions too, such as Precursor Cell Lymphoblastic Leukemia-Lymphoma: 4,428 studies, 824 open.

Get an email when these change. Save the Leukemia, Lymphoid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
51
Recruiting
12
Terminated
11
Active, not recruiting
10
Withdrawn
2
Status unknown
2

Phase

Phase 2
45
Phase 1
34
Phase 3
5
Early Phase 1
3
Phase 4
2

Where

United States
64
China
8
Italy
7
France
6
Spain
5
Germany
4

Who runs them

H. Lee Moffitt Cancer Center and Research Institute (5) · Pharmacyclics LLC. (4) · University of Wisconsin, Madison (3) · Sichuan University (3) · National Cancer Institute (NCI) (3) · Fred Hutchinson Cancer Center (3) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Stanford University (2)

What is being tested here

Drugs under test in Leukemia, Lymphoid studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cyclophosphamide205
Blinatumomab204
Fludarabine107
Busulfan106
Pirtobrutinib112
Thiotepa101
Allogeneic CD34+-enriched and CD45RA-depleted PBSCs101
Methotrexate101
Mosunetuzumab101
Riluzole101

Drug classes tested here Alkylating agents 2 open · Tyrosine kinase inhibitors (TKIs) 1 open · Antimetabolites 1 open

Coming up

1phase 3 study under way
7studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7, phase 3 first

Who these studies take

Of the 12 Leukemia, Lymphoid studies recruiting now, 6 (50%) set no upper age limit and 6 (50%) stop at 75 or younger. 6 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
104 (33%)4 (33%)
1810 (83%)10 (83%)
308 (67%)8 (67%)
408 (67%)8 (67%)
509 (75%)9 (75%)
658 (67%)8 (67%)
757 (58%)7 (58%)
856 (50%)6 (50%)

Across all 92 studies, recruiting or not: 32% stop at 75 or younger and 24% at 65; 26% take children; 0% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 92. Browse all 92 → or search them.